Clinical Trial Update: A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult Participants [Phase 2]

View source ↗

Summary

A Phase 2 trial assessed REGN9933 for preventing venous thromboembolism after knee replacement surgery; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• REGN9933

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Venous Thromboembolism | Phase 2 | Status: COMPLETED | Results posted: 2025-07-16